이머전트 바이오솔루션스(주)
US ˙ NYSE ˙ US29089Q1058

SecurityEBS / Emergent BioSolutions Inc.
InstitutionLsv Asset Management
Latest Disclosed Ownership896,700 shares
Latest Disclosed Value $ 7,443
Lsv Asset Management reports 0.48% decrease in ownership of EBS / Emergent BioSolutions Inc.

On May 11, 2026 - Lsv Asset Management filed a 13F-HR form disclosing ownership of 896,700 shares of Emergent BioSolutions Inc. (US:EBS) valued at $7,442,610 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 901,000 shares of Emergent BioSolutions Inc.. This represents a change in shares of -0.48% during the quarter. The current value of the position is $7,236,369 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Emergent BioSolutions COM 29089Q105 896,700 -4,300 -0.48 7 -36.36 0.0160
2026-02-06 2025-12-31 13F Emergent BioSolutions COM 29089Q105 901,000 36,500 4.22 11 57.14 0.0243
2025-11-06 2025-09-30 13F Emergent BioSolutions COM 29089Q105 864,500 48,909 6.00 8 40.00 0.0168
2025-08-11 2025-06-30 13F Emergent BioSolutions COM 29089Q105 815,591 -15,600 -1.88 5 25.00 0.0122
2025-05-09 2025-03-31 13F Emergent BioSolutions COM 29089Q105 831,191 809,591 3,748.11 4 0.0097
2025-02-13 2024-12-31 13F Emergent BioSolutions COM 29089Q105 21,600 21,600 0 0.0005
2023-11-03 2023-09-30 13F Emergent BioSolutions COM 29089Q105 0 -40,700 -100.00 0 0.0000
2023-08-02 2023-06-30 13F Emergent BioSolutions COM 29089Q105 40,700 -30,576 -42.90 0 0.0007
2023-05-02 2023-03-31 13F Emergent BioSolutions COM 29089Q105 71,276 -34,400 -32.55 1 -100.00 0.0017
2023-02-08 2022-12-31 13F Emergent BioSolutions COM 29089Q105 105,676 0 0.00 1 -99.95 0.0028
2022-11-07 2022-09-30 13F/A-1 Emergent BioSolutions COM 29089Q105 105,676 0 0.00 2,218 -32.38 0.0052
2022-11-04 2022-09-30 13F Emergent BioSolutions COM 29089Q105 105,676 0 3,280 0.0071
2022-08-10 2022-06-30 13F Emergent BioSolutions COM 29089Q105 105,676 0 0.00 3,280 -24.41 0.0071
2022-05-12 2022-03-31 13F Emergent BioSolutions COM 29089Q105 105,676 14,200 15.52 4,339 9.13 0.0080
2022-01-28 2021-12-31 13F Emergent BioSolutions COM 29089Q105 91,476 61,176 201.90 3,976 162.10 0.0070
2021-11-04 2021-09-30 13F Emergent BioSolutions COM 29089Q105 30,300 0 0.00 1,517 -20.49 0.0027
2021-08-04 2021-06-30 13F Emergent BioSolutions COM 29089Q105 30,300 0 0.00 1,908 -32.22 0.0032
2021-04-30 2021-03-31 13F Emergent BioSolutions COM 29089Q105 30,300 -2,700 -8.18 2,815 -4.77 0.0048
2021-02-08 2020-12-31 13F Emergent BioSolutions COM 29089Q105 33,000 7,100 27.41 2,956 10.46 0.0054
2020-10-23 2020-09-30 13F Emergent BioSolutions COM 29089Q105 25,900 0 0.00 2,676 30.66 0.0055
2020-08-05 2020-06-30 13F Emergent BioSolutions COM 29089Q105 25,900 -4,600 -15.08 2,048 16.10 0.0042
2020-05-07 2020-03-31 13F Emergent BioSolutions COM 29089Q105 30,500 30,500 1,764 0.0043
2019-02-05 2018-12-31 13F Emergent BioSolutions COM 29089Q105 0 -17,700 -100.00 0 -100.00
2018-11-06 2018-09-30 13F Emergent BioSolutions COM 29089Q105 17,700 -53,700 -75.21 1,165 -67.67 0.0017
2018-08-08 2018-06-30 13F Emergent BioSolutions COM 29089Q105 71,400 -144,200 -66.88 3,604 -68.25 0.0056
2018-05-04 2018-03-31 13F Emergent BioSolutions COM 29089Q105 215,600 -530,918 -71.12 11,351 -67.28 0.0180
2018-01-31 2017-12-31 13F Emergent BioSolutions COM 29089Q105 746,518 90,971 13.88 34,690 30.83 0.0548
2017-11-13 2017-09-30 13F Emergent BioSolutions COM 29089Q105 655,547 20,832 3.28 26,516 23.20 0.0437
2017-08-09 2017-06-30 13F Emergent BioSolutions COM 29089Q105 634,715 12,000 1.93 21,523 19.02 0.0383
2017-05-01 2017-03-31 13F Emergent BioSolutions COM 29089Q105 622,715 78,500 14.42 18,083 1.18 0.0330
2017-02-07 2016-12-31 13F Emergent BioSolutions COM 29089Q105 544,215 159,680 41.53 17,872 47.41 0.0329
2016-11-07 2016-09-30 13F Emergent BioSolutions COM 29089Q105 384,535 82,500 27.31 12,124 42.75 0.0238
2016-08-05 2016-06-30 13F Emergent BioSolutions COM 29089Q105 302,035 90,038 42.47 8,493 10.21 0.0174
2016-05-10 2016-03-31 13F Emergent BioSolutions COM 29089Q105 211,997 -98,500 -31.72 7,706 -37.96 0.0161
2016-02-03 2015-12-31 13F Emergent BioSolutions COM 29089Q105 310,497 125,017 67.40 12,422 135.09 0.0270
2015-11-05 2015-09-30 13F Emergent BioSolutions COM 29089Q105 185,480 6,878 3.85 5,284 -10.20 0.0119
2015-08-07 2015-06-30 13F Emergent BioSolutions COM 29089Q105 178,602 60,936 51.79 5,884 73.88 0.0122
2015-05-06 2015-03-31 13F Emergent BioSolutions COM 29089Q105 117,666 117,666 0.00 3,384 0.0070
2015-02-04 2014-12-31 13F Emergent BioSolutions COM 29089Q105 0 -4,900 -100.00 0 -100.00
2014-11-12 2014-09-30 13F Emergent BioSolutions COM 29089Q105 4,900 0 0.00 104 -5.45 0.0002
2014-08-06 2014-06-30 13F Emergent BioSolutions COM 29089Q105 4,900 4,900 110 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.